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While computed tomography and other imaging techniques are measured in absolute units with physical
meaning, magnetic resonance images are expressed in arbitrary units that are difﬁcult to interpret and dif-
fer between study visits and subjects. Much work in the image processing literature on intensity normal-
ization has focused on histogram matching and other histogram mapping techniques, with little emphasis
on normalizing images to have biologically interpretable units. Furthermore, there are no formalized prin-
ciples or goals for the crucial comparability of image intensities within and across subjects. To address this,
we propose a set of criteria necessary for the normalization of images. We further propose simple and ro-
bust biologically motivated normalization techniques for multisequence brain imaging that have the same
interpretation across acquisitions and satisfy the proposed criteria. We compare the performance of differ-
ent normalization methods in thousands of images of patients with Alzheimer's disease, hundreds of
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1. Introduction
Complex multi-modality, cross-sectional and longitudinal imaging
studies are now commonplace in medical research and clinical practice.
Such studies produce terabytes of highly complex data, cost millions of
dollars, and require years to decades of follow-up. Many such studies
havealreadybeen conductedandarecurrentlyunderwaytoinvestigate
a diverse collection of disabling and fatal diseases. Most of these studies
include multisequence magnetic resonance imaging (MRI) to assess
structural differences and changes in the brain. The nature of convention-
al MRI units makes direct quantitative analysis difﬁcult; in particular, MRI
scans are acquired in arbitrary units that are not comparable between
study visits within a single subject nor across different subjects.
The image analysis literature has emphasized the importance of
intensitynormalization (whichwe referto asnormalization for brevity)
for registration (Hellier, 2003), cross-sectional (Wang et al., 1998; Shah
et al., 2011) and longitudinal (Sweeney et al., 2013a) segmentation,
longitudinal quantiﬁcation (Meier and Guttmann, 2003), and other
measures (Madabhushi et al., 2006; Loizou et al., 2009). Much work
over the past two decades has aimed to address this issue with limited
success (Nyul and Udupa, 1999; Nyul et al., 2000; Weisenfeld and
Warﬁeld, 2004; Jäger et al., 2006; Madabhushi and Udupa, 2006;
Leung et al., 2010) (for a comprehensive review of these methods, see
Shah et al., 2011). However, as the goals of normalization have not
been formalized, the comparison of these methodologies is difﬁcult. As
intensity normalization is often also a preprocessing step for later anal-
yses,in each such case these analytical goals aremost relevant. Further-
more, all previously proposed methodssuffer from thelack of biological
interpretability of the normalized units.
Our goal is to propose an explicit statistical framework for image in-
tensity normalization, develop a new class of robust intensity normali-
zation methods for studying the brain through MRI, and deploy them
on thousands of images from the Australian Imaging, Biomarkers and
Lifestyle Flagship Study of Aging(AIBL), theAlzheimer's Disease Neuro-
imaging Initiative (ADNI), and two large studies of multiple sclerosis
(MS) acquiredusinga varietyof scanners andprotocols.In thenextsec-
tion, we describe a set of criteria that formalize the goals of normaliza-
tion. We then describe a novel statistical normalization methodology
and the results from this simple technique, and we conclude with a
discussion.
2. Materials and methods
2.1. Principles of image normalization
Consider the image intensity Yij(v)a te a c hv o x e lv expressed in
arbitraryunitsandmeasuredforsubjectiatvisitjusingaparticularmo-
dality. Normalization is any transformation of the type Yij(v) → Nij
{Yij(v)}. It is useful to conceptualize the histogram of intensities Yij(v)
as a mixture of densities:
f ij x ðÞ ¼
X K
k¼1
wijkf ijk x ðÞ ; ð1Þ
where fijk(x) is the subject/visit-speciﬁc intensity densities of empty
spaceandknown tissues,suchaswhitematter,graymatter,cerebrospi-
nal ﬂuid, bone, skin, and lesions. The weights wijk ≥ 0s u mt o1a n dr e p -
resent the relative weights of components k =1 ,…, K. This includes
both cases with and without pathology, as the weight for lesions or
other abnormal tissues can be zero. Note that the densities fijk(x) and
weights wijk are not directly observed, but may be estimated by ﬁrst
segmenting the images and estimating wijk using the proportion of the
image in the k-th tissue class and fijk(x) by the histogram of intensities
in that tissue.
The quantitative analysis of images assumes the existence of a
theoretical model in normalized space for all images: gij(x)=
∑ k =1
K wijkgk(x), where the densities gk(x) are independent of subjects
and/or visits, though the weights assigned to these densities depend on
subjectand visit andmay be themeasureof interest instudies.The funda-
mental difﬁculty of normalization is to ﬁnd a transformation from fij(x)t o
gij(x) that respects the ordering of distributions and their mutual dis-
tances in the normalized space, and thus we denote a normalized density
by ^ gij x ðÞ for clarity.
Although the fundamental importance of intensity normalization
has been emphasized by numerous publications in the imaging litera-
ture (Shah et al., 2011; Nyul and Udupa, 1999; Weisenfeld and
Warﬁeld, 2004), no formal guiding principles nor deﬁnitions have
been established. We introduce a set of 7 principles, which we refer to
as the statistical principles of image normalization (SPIN).
The normalization process should produce units that:
1. have a common interpretation across locations within the same tis-
sue type
2. are replicable
3. preserve the rank of intensities
4. have similar distributions for the same tissues of interest within and
across patients
5. are not inﬂuenced by biological abnormality or population
heterogeneity
6. are minimally sensitive to noise and artifacts and
7. do not result in loss of information associated with pathology or
other phenomena.
SPIN is motivated by the goal of population-level analysis that
respects the structure of images while requiring the comparability of
replicable and biologically meaningful units within tissue types within
and across subjects. The preservation of ranks avoids situations where
normalized image comparisons are discordant with comparisons
madeusingrawunitswithinasubject,andtherequirementsofminimal
sensitivity to noise, population heterogeneity, and pathology aim to
avoid spurious ﬁndings.
In the absence of SPIN, much of the work on normalization has
progressed with little objective quantiﬁcation or validation. To assess
SPIN,severalmetricsmaybeappropriate:SPIN1 depends on thedeﬁni-
tion of the normalization and is crucial for the population-level inter-
pretability of statistical inference from the image intensities. SPIN 2
may be assessed using simulations, or the analysis of data containing
replicates. SPIN 3 requires Nij(⋅) to be a strictly increasing function.
Careful inspection of SPIN 4 suggests that after normalization fijk(⋅)
should be as close to one another as possible for all i and j and for any
ﬁxed k. Thus, a natural starting point would be to consider transforma-
tions that reduce the distance between the fijk(x) for any ﬁxed k. SPIN
5–7 require validation studies in large biologically heterogeneous pop-
ulations with varying levels of noise and artifacts, and SPIN 7 may be
more difﬁcult to quantify. Although no single normalization method
may be available to satisfy all 7 SPIN criteria simultaneously, depending
on the particular goal of a planned analysis each criterion may be
assessed andimplicationsof anyviolationsmust becarefully examined.
The most common approach for normalization, proposed by Nyul
and Udupa (1999) and reﬁned by Shah et al. (2011) and Nyul et al.
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two stages: the ﬁrst stage creates a template histogram, say γ(x), with
landmarks of interest usually through averaging histograms in a refer-
ence population (Nyul et al., 2000). Then, for each subject in the
study, the histograms of each subject are mapped fij(x) via a piecewise
linear transformation to the template deﬁned using quantiles as knots.
This process is computationally fast and has proven helpful for lesion
segmentation as shown in Shah et al. (2011). These methods may be
useful in very limited scenarios, but often result in severe violations of
SPIN: ﬁrstly,thevariation in intensities is difﬁcult to interpret. Although
histogram matching methods produce replicable results, they are based
on suspect assumptions: 1) the distribution of tissue-type is the same
acrosssubjectsandvisits(seetheResultssectionandFig.1); 2)subjects'
brains do not have abnormal pathology (Nyul et al., 2000); and 3) tech-
nical artifacts (for example, from patient motion and residual spatial
inhomogeneity after correction (Shah et al., 2011)) do not exist.
This makes histogram matching inappropriate for any study of images
from multiple subjects. Our comprehensive study of histogram-
matchingmethodsindicatesthattheseapproaches leadtothefalse ero-
sion of GM on a magnitude much larger than would be expected from,
say, the natural progression of Alzheimer's disease (AD) (~2% gray
matter erosion per year (Anderson et al., 2012)). Such failures are crip-
pling to many quantitative studies of anatomical development and
etiology.
Our interest lies in developing principled statistical methods for
normalizingimages to ensure comparability within and across subjects.
In the remainder of this paper, we introduce a formal statistical frame-
work and propose statistically principled methods for generalizable
and robust inference from large MRI studies. Given the large number
of images we intend to normalize (thousands to tens of thousands),
the procedure proposed needs to be fully automatic and fast. This re-
quires the robust and rapid identiﬁcation of the normal-appearing
white matter (NAWM) in each subject at each study visit. In previous
studies, Shinohara et al. (2011) used a white-matter mask based on
the Lesion-TOADS (Shiee et al., 2010) segmentation algorithm. The
problem with such an approach is that it can be slow (45 min per
image), it requires manual tuning of segmentation parameters, and its
performance can be sensitive to heterogeneity in large imaging studies.
Wesuspectthatthismaybeduetotheuseofunsupervisedmethodsfor
image segmentation using unnormalized data. To avoid this, we pro-
pose a faster and more robust approach.
2.2. Study populations
We ﬁrst study two large populations consisting of healthy subjects,
subjects with mild cognitive impairment (MCI), and subjects with AD.
The ﬁrst is the ADNI database (adni.loni.ucla.edu). In the data analyzed
in this paper, we consider 616 adults aged 55 to 90 consisting of cogni-
tively normal older individuals, people with MCI, and people with early
AD who were imaged longitudinally at 1427 study visits (1–7v i s i t sp e r
subject). The second source of data was collected by the AIBL study
group. AIBL study methodology has been reported previously (Ellis
et al., 2009), and 262 cognitively normal older individuals, people
with MCI, and people with early AD aged 55to 90were imagedlongitu-
dinally (1–2 visits per subject) at 442 study visits.
We also consider two studies of multiple sclerosis (MS) from two
different centers in the US. The Neuroimmunology Branch of the Na-
tional Institute for Neurological Disorders and Stroke (NINDS) and the
Department of Neurology and Neurosurgery at the Johns Hopkins
School of Medicine are simultaneously acquiring MRI for the long-
termstudyofthenaturalhistoryandtreatmentofMS.Fromtheseongo-
ing separate studies, we consider 242 (99 from Johns Hopkins and 143
from NINDS) patients with MSscanned under a diversecollection of ac-
quisition protocols and scanners. Clinical summaries of the population
of MS subjects studied in this work are described elsewhere (Sweeney
et al., 2013b).
2.3. Imaging sequences and preprocessing
From the ADNI and AIBL studies, we consider T1-weighted (T1-w)
MP-RAGE and T2-weighted (T2-w) imaging acquired on 1.5 and 3 T
scanners according to the standardized protocol (Jack et al., 2008). For
the studies of MS at Johns Hopkins and NINDS, we analyze T1-w and
T2-w imaging acquired under protocols on 3 T scanners described else-
where(Sweeneyetal.,2013a,2013b).Allimagepreprocessingwascon-
ducted using the Medical Image Processing, Analysis and Visualization
(http://mipav.cit.nih.gov) software environment through the Java
Image Science Toolkit (Lucas et al., 2010). All images were corrected
for spatial inhomogeneity (Sled et al., 1998) and rigidly aligned across
modalities at each study visit to the Montreal Neurological Institute
template. For performance assessment within tissue types, TOADS
(Bazin and Pham, 2007) was used for segmentation of the brain in the
AD studies, and LesionTOADS (Shiee et al., 2010) was used in MS studies.
These segmentations were not used for any normalization technique de-
scribed below, but only for performance assessment.
Fig. 1.Schematicshowingtheproposednormalizationtechniques. Thesteps shown inthe
cyan region are standard preprocessing steps, while the green region shows the white
stripe normalization algorithm. The bottom right section in purple shows the hybrid
white stripe normalization technique.
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The goal of our method is to minimize the discrepancy between the
distributions of intensities fijk(⋅) across subjects and visits within tissue
classes while respecting SPIN. We call this tissue-speciﬁc histogram
normalization. We propose to accomplish this by focusing on matching
moments of the distribution in a particular reference tissue and appro-
priately adjustingtheintensity distribution in other tissues accordingly.
Assume for the moment that, for every subject and visit, we have an
area of white matter (a sub-mask of the white matter). Then we can ac-
curately estimate the distribution function fij1(x)( s a yk = 1 for white
matter) for each i and j and obtain a normalized estimator that has a
mean of zero and a variance of one, ^ gij1 x ðÞ¼ σij1f ij1 μij1 þ σij1x
  
,
where μij1andσij1arethemeanandstandarddeviationoffij1(x),respec-
tively. An estimatorof the normalized histogramacrosstheimageusing
linear normalization with respect to the white-matter distribution is:
^ gij x ðÞ ¼ σij1f ij μij1 þ σij1x
  
¼
X K
k¼1
wijk σij1f ijk μij1 þ σij1x
   hi
: ð2Þ
Allunitsareexpressedinmultiplesofstandarddeviations,σij1,ofthe
white-matter intensities, and zero is the average intensity of white
matter. Note that the densities fijk(⋅) and weights wijk are theoretical
and need not be estimated in practice (except for fij1(⋅) as described
above). This method was used in several papers (Sweeney et al.,
2013a;Shinoharaetal.,2011),thoughitwasneverproposedasaformal
normalization procedure and its statistical properties for normalizing
other tissues have not been investigated.
Consider a T1-weighted structural MR image, Yij(v). The proposed
normalization techniques are shown in a ﬂow diagram in Fig. 1.W e
use NAWM as a reference tissue, since it is the most contiguous brain
tissue and therefore least confounded by partial volume averaging and
is, by deﬁnition, not obviously affected by pathology (leadingto confor-
mity to SPIN 5). To identify the distribution of NAWM intensities, we
ﬁrst isolate a rectangle containing the measured intensities within an
α = 4 cm section at the center of the head (using a fast rigid alignment
to theMontreal Neurological Institutetemplate).The thickness α of this
section was chosen empirically (see Fig. A.3 for a sensitivity analysis).
We then use a penalized spline smoother (Ruppert et al., 2003), a fully
automatic smoothing technique that estimates the smoothing parame-
ter, to estimate the mode μij1
∗ (the largest non-background peak) of the
intensityhistogramin whitematterbased on this rectangle. Toestimate
the variability within NAWM on the raw image, we estimate the stan-
dard deviation σij1
∗ of intensities within Ωi,j,τ ={ v : Fij
−1[F(μij1
∗ ) − τ] b
Yij(v) b Fij
−1[F(μij1
∗ )+τ]}, which we call the white stripe (where
Fij(x)=∫ −∞
x fij(x) dx). Here τ is a quantile tolerance in the original
space of intensities. We found several values to work well in practice
and used τ = 0.05 after conducting a sensitivity analysis (see
Appendix B). The estimation of μij1
∗ and σij1
∗ has been found to be re-
markably robust across thousands of images (failure rate b 1%, 15 out of
2109 study visits). If the family of densities fij1(v) can be parameterized
by two parameters then μij1 = ψ1(μij1
∗ , σij1
∗ ) and σij1 = ψ2(μij1
∗ , σij1
∗ )
(proof follows from the method of moments). Thus, matching μij1
∗ and
σij1
∗ (estimable directly from the white stripe without priorsegmentation)
results in matching μij1 and σij1. This process, which we refer to as white
stripe normalization, is demonstrated visually for a single image in Fig. 2.
For multimodal imaging, including multi-sequence MR imaging ac-
quired in the studies of interest, the above normalization technique
does not apply directly. To address this, we ﬁrst propose the rigid
Raw Image
Histogram-Matched
A
C
B
D
Raw Histogram
Matched Histogram
Histogram - Proposed Normalization
F
Proposed Normalization
E
-6
149
0
1
-77
94
Fig. 2. Failure of histogram matching methods. First column: region of interest from patient with MCI shown before (A) and after (C) histogram matching. Red square indicates region of
gray matter on raw image that disappears after histogram matching. Second column: histograms (shades of gray indicate different study visits) of the gray matter before (B) and after
(D) histogram matching for subjects in ADNI. Note the large proportion of gray matter incorrectly matched to background (zero intensity). The green line shows the histogram for the
image shown in the left column. (E) and (F) show the same image and histograms after the normalization proposed in this paper.
12 R.T. Shinohara et al. / NeuroImage: Clinical 6 (2014) 9–19alignment of the multi-modality imaging using standard techniques
within each study visit. This robust procedure produces a four-
dimensional image Yij
(m)(v)f o rm =1 ,…, M where M is the number of
modalities acquired. Fortunately, in almost all modern research MRI
protocols the acquisition of a high-resolution T1-w image is a key com-
ponent. Thus, to extend the methods developed above, we consider the
use of the white stripe method on the T1 image Yij
(1)(v)t oe s t i m a t et h e
white stripe Ωi,j,τ
(1). Then, for each modality m, we estimate the white
stripe moments μij1
(m) ∗ and σij1
(m) ∗. We then normalize each modality by
calculating{Yij
(m)(v) − μij1
(m) ∗}/σij1
(m) ∗. An alternate approachis tonormal-
ize by using our peak-ﬁnding algorithm to ﬁnd the largest non-
background mode in the histogram on modality m, and use this to
form thewhite stripe Ωi,j,τ
(m). Note that this peak does not necessarily cor-
respond to NAWM alone on all imaging modalities; in particular, the
white stripe estimation applied directly to T2-weighted imaging yields
a mixture of GM and WM intensities since these are similar. This results
in good performance for normalization of both tissue classes, but excel-
lent performance for neither. A natural extension of this idea is to nor-
malize using tissue from the white stripe in all classes; that is,
normalizing with respect to Ωi,j,τ
hybrid = ∩ mΩi,j,τ
(m) allows comparability in
terms of a more speciﬁcd e ﬁnition across modalities. Thus, in the
Results section, we compare these three proposed normalization
methods: 1) the T1-based white stripe, which normalizes the data
based on Ωi,j,τ
(1); 2) the T2-based white stripe, based on Ωi,j,τ
(2);a n d3 )ah y -
brid white stripe using Ωi,j,τ
hybrid.
To assess the performance of the various methods described above,
we propose a new generalization of variance for probability densities
to quantify variability before and after normalization as measure of
SPIN 4. From the theory of U-statistics (Hoeffding, 1948), the sample
variance∑ l;k ðÞ ∈Γ
 ∫
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
f l u ðÞ
q
−
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
f k u ðÞ
q    2
du=2jΓ
 jwhere Γ⁎ is a random-
ly chosen sufﬁciently large subset of Γ (for this study we used |Γ
∗|=
2000). Asymptotic properties of our estimated variance of densities fol-
low from standard U-statistic arguments as the number of densities
under study increases.
3. Results
All images from the four studies were normalized using the histo-
gram matching-based approach (Shah et al., 2011; Nyul and Udupa,
1999), and the T1-based, T2-based, and hybrid white stripe methods
proposed in the Methodology section. Fig. 1 shows how the faulty as-
sumption made by histogram matching of common distributions of tis-
sue throughout the head causes severe mismatching of gray matter
(GM) to cerebrospinal ﬂuid (CSF); note how a normal-appearing part
ofthebrain(rawdatashowninFig. 1A)isinducedtoshowmassiveero-
sion of GM by histogram normalization (histogram normalized data
shown in Fig. 1C). Such failures arecripplingto many quantitative stud-
ies of anatomical development and etiology. The results from our pro-
posed T1-based normalization method are shown in Fig. 1E and F and
demonstrate signiﬁcant improvementover histogrammatching. An ad-
ditional example for visual inspection is shown in Figs. A.10 and A.12 of
the Appendix, and an example of severe erosion in an imaging study
0 500 1000 1500 2000 2500 3000 0 500 1000 1500 2000 2500 3000
−60 −40 −20 0 20 −50 −40 −30 −20 −10 0 10 20
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Fig. 3. Example of the white stripe normalization procedure. In the top left plot, the raw histogram of a T1-w image is shown. Using a peak-ﬁnding algorithm, μij1
∗ and thus Ωi,j,τ are
estimated. In the right column of the ﬁgure, Ωi,j,τ is shown before and after normalization. The density of the intensities in NAWM before (fij1) and after normalization ^ gij2
  
is shown
using dashed magenta lines. The bottom left plot shows the histogram after white stripe normalization.
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A.13.
Simulations were conducted to validate the performance of the pro-
posed image normalization methodology, and the results are provided
in Appendix A. To visually assess the performance of differing normali-
zation methods across the four MRI studies, the histograms of the T1-w
and T2-w images are displayed in Fig. 3 for the AD studies and Fig. 4 for
the MS studies. Each line corresponds to a study visit where color
indicates the study and differing shades are for clarity in illustration.
In Fig. 3,t h eﬁrst two columns correspond to the T1-w and T2-w den-
sities in cerebral white matter and the second two correspond to the
gray matter. In Fig. 4, the last two columns correspond to white matter
lesions.
The results below do not include 15 study visits (0.7%) across the
four studies on which our peak-ﬁnding algorithm failed. These were
identiﬁed via manual inspection, and this failure was attributable to
very severe chronic MS (2 patients), diffuse vascular white matter dis-
ease (5 patients), and high BMI resulting in excess fat in the scalp (5
subjects, mean BMI = 32.4). For obese subjects, standard fast skull-
stripping algorithms, such as FSL BET (Smith, 2002), solves these issues
associated with excess extracranial fat. Each of these subjects shows
that in severe cases of pathology and in some outliers, SPIN 5 may be
violated.
The heterogeneity in raw intensities across scans shows variability as
expected, even in the ADNI and AIBL studies where protocols were man-
dated in advance and tightly controlled. The histogram-transformed
Fig. 4. Histograms of intensities before and after normalization by tissue type in two large studies of AD. Rows indicate different normalization methods and columns correspond to MR
sequence and anatomical structure.
14 R.T. Shinohara et al. / NeuroImage: Clinical 6 (2014) 9–19intensities (second row of Figs. 3 and 4) also show signiﬁcant variability
as well as mismatching as described in Fig. 1. The T1-based white stripe
shows good comparability of the NAWM distributions across subjects
and visits on the T1-w imaging, but less comparability in the T1-w GM.
This is expected due to the partial volume averaging of GM voxels with
WM and CSF, and the differentialWM to GM contrast ratios across images
and protocols. The T2-w NAWM also shows large heterogeneity under
the T1-based white stripe normalization, especially in the Hopkins
study. The T2-based white stripe shows generally good comparability
on the T1-w imaging in both the WM and GM, and especially good com-
parability on the T2-w imaging. However, the proposed T1-based method
shows slightly closer T1-w distributions in the NAWM. Finally, the hybrid
method shows similar performance to the T1-based method on T1-w im-
aging, and near identical performance to the T2-based method on T2-w
imaging. In MS lesions, the T1-based and hybrid white stripe methods
show moderate comparability across subjects on T1-w imaging. This is
likely due to the much greater biological heterogeneity in these regions.
TheT2-basedand hybridwhitestripemethods resultingood comparabil-
ity across subjects on T2-w imaging in the Hopkins study, but poor com-
parability acrosssubjectsin the NINDS study likely due to the much larger
range in scanning parameters. Figs. A.5–A.7 of the Appendix show the re-
sults from the AD studies separated by baseline diagnosis, and Figs. A.8–
A.9 show the results from the MS studies separated by lesion load. The
white stripe methods perform similarly independent of disease severity.
To assess these comparisons quantitatively, we use the Hellinger
distance-based variance proposedin the Methodology section.Our pro-
posedvariancemeasuresheterogeneityinasampleofdensities;smaller
values of this quantity within tissue types indicate better comparability
(SPIN 4). Furthermore, lower variance in large heterogeneous imaging
studies suggests more replicable measurements (SPIN 2), low sensitivi-
ty to the spectrum of biological abnormality (SPIN 5), and low sensitiv-
ity to minor noise and artifacts (SPIN 6).
The results from these variance calculations are shown in Fig. 6.T h e
performanceof thehybrid whitestripe method is superior to otherpro-
posed methods in most cases, including the histogram matching meth-
od. As noted above in Figs. 4 and 5, the hybrid method shows small
variances in the NAWM and WM lesion in all modalities and low
variance in the GM on the T2-w imaging. The large variance in the T1-
w densities in the GM reﬂects the nature of the white stripe normaliza-
tion; if the primary goal of interest is to study GM on T1-w imaging, a
normalization targeted speciﬁcally to gray mattermotivated by thepro-
posed white stripe method might be appropriate.
4. Discussion
We have introduced SPIN, a setof principlesfor imagenormalization
and an explicit framework based on mixtures of distributions, where
each fundamental distribution has a physical interpretation. Although
intensity normalization has been acknowledged as crucial for the quan-
titative analysis of MRI, there are currently no automatic methods for
statistical intensity normalization of brain MRI that satisfy the basic re-
quirements of SPIN. In addition, confounding due to acquisition- and
subpopulation-related differences across scanners and study sites is
moreproblematicinincreasinglymorecommonmulti-modalitystudies
that require more complex protocols.
We propose the ﬁrst methodology for the statistical normalization of
neuroimaging that satisﬁes SPIN. Our methods require less than 5 s of
computationtimeon a standard laptop perMRI scan, makingthem highly
suitable for routine use in clinical practice and research. Using fast, scal-
able, and fully automatic coarse segmentation techniques, we suggest a
simple and robust technique for estimating parameters of the NAWM dis-
tribution in an image. These parameters are matched across visits and
subjects to yield simple and clearbiologicalinterpretations. This approach
Fig. 5. Histograms of intensities before and after normalization by tissue type in two large studies of MS. Rows indicate different normalization methods and columns correspond to MR
sequence and anatomical structure.
15 R.T. Shinohara et al. / NeuroImage: Clinical 6 (2014) 9–19is robust to artifact and pathology and allows for generalizable inference
to large multi-center imaging studies.
Our proposed methodology satisﬁes SPIN under many circum-
stances through a subject/visit-speciﬁc linear transformation of intensi-
ties resulting in the same physical interpretation across subjects and
visits. In addition, using information across imaging modalities jointly
allows for more precise normalization with similar simple interpreta-
tion of units across modalities. Using precursors to this methodology
(Sweeney et al., 2013a, 2013b) we have found dramatically improved
lesion detection performance cross-sectionally and longitudinally; the
methods proposed here promise further improvement in performance
and dramatically reduced computational requirements.
Ourmethodsaim to matchtheintensityoftissueswithout upsetting
the natural balance of tissue intensities. When this is not possible, we
characterize how far apart the tissue-speciﬁc components are. This
approach is fundamentally different from the normalization algorithms
common in genomics (for example, see Irizarry et al., 2003), which are
dedicated to matching distributions with one component. Instead, we
propose intensity normalization approaches for mixtures of densities
where each density has a physical interpretation, using a pre-selected
reference tissue type. The results from our analyses indicate good com-
parability across study visits, subjects, study centers, and highly hetero-
geneous scanning protocols. Although we present our methods in the
context of T1-w and T2-w MRI of the brain, our methods may be natu-
rallyextendedtootherimagingmodalitiesusedthroughoutthebody.In
some scenarios, the coarse segmentation used here may not perform
well and alternative segmentation methods may be more appropriate
for segmenting a reference tissue.
Although the T1-based method conforms to SPIN, the proposed T2-
based method violates SPIN for normalizing T1-w imaging. First, as the
relative proportions of WM and GM vary from patient to patient, SPIN
4 is violated. Furthermore, as patients with varying severity of diseases
such asAD and MS have varyingloss of GM, SPIN 5 does not hold. How-
ever, as the distribution of T2-w intensities in the WM and GM are sim-
ilar,applyingtheT2-basednormalizationtotheT2-wimagingconforms
to SPIN. The hybrid white stripe method, which performs similarly to
the modality-speciﬁc normalizations on the appropriate images, does
notresultin anymajorviolationsofSPINandin mostcases dramatically
improves the comparability of imaging across study visit, subjects, and
study protocols.
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Table 1
Parametersusedinthesimulationstudy.Theparameterσμisthestandarddeviationofthe
means across tissue classes across subjects, and σW is the standard deviation of intensities
within each tissue class.
Simulation setting σμ σW
1 0.10 1
2 0.10 2
3 0.10 5
4 0.25 1
5 0.25 2
6 0.25 5
7 0.5 1
8 0.5 2
9 0.5 5
16 R.T. Shinohara et al. / NeuroImage: Clinical 6 (2014) 9–19While the proposed techniques involve the normalization with
respect to a particular reference tissue, extensions might involve the
normalization of each tissue class individually. However, this would in-
duce dependency on the accuracy of segmentation which may not be
desirableinmanycasesoflargeimagingdatabaseswheresegmentation
remains difﬁcult. Furthermore, artifacts from patient motion and other
sources could be problematic as they are known to affectsegmentation,
which could then also affect the normalization.
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Appendix A. Simulation studies
To investigate the performance of the proposed white stripe nor-
malization techniques, we conducted a series of simulation studies.
We used the two-dimensional image template shown in Fig. A.1 and
sampled n = 100 subject images using the intensity data generating
distribution:
Yi v ðÞ ∼ZSHIFT;i þ Z
2
SCALE;i
 
N 20;σW ðÞ for v in NAWM
N 10 þ ZGM;i;σW
  
for v in GM
N 10 þ Zlesion;i
  
;σWÞ for v in lesion
N 10 þ ZBG;i
  
;σWÞ for v in background
8
> > > > > <
> > > > > :
where ZSHIFT,i,a n dZSCALE,i ∼ N(0, 1) are latent subject-level whole-image
shift and scale random variables, and ZGM,i, Zlesion,i, and ZBG,i ∼ N(0, σμ)
are latent tissue-speciﬁc shifts. We simulate data under the nine scenarios
of varying values of the parameters σμ and σW as shown in Table 1.T h e
performance of the white stripe normalization applied to the raw intensi-
ties Yi(v)i ss h o w ni nFig. A.2, and the method performs well throughout.
The white stripe normalization shows least beneﬁt in setting 7 for which
thevariabilityinmeansacrosstissueclassesismostsimilartothevariabil-
ity within tissue classes; this is a difﬁcult case in which a highly nonlinear
normalization would be necessary to improve normalization perfor-
mance in the GM and lesion tissue classes, and such techniques require
further study.
Appendix B. Sensitivity analyses for α and τ
To assess the sensitivity of theproposed methodology to thespeciﬁ-
cation of the parameter α, we reanalyzed the data from the MS study at
NINDS across a variety of values of α. The results from this analysis are
shown in Fig. A.3, and show relative stability in the normalization for
the T1-based, T2-based, and hybrid white stripe normalizations for α
ranging from 20 mm to 80 mm. We chose to use the 40 mm thickness
as it was optimal in the NAWM, and also because differential BMI and
other extracerebral tissue factors resulted in poor differentiation of the
NAWM peak in some studies for larger thicknesses.
To assess the sensitivity of theproposed methodology to thespeciﬁ-
cation of the parameter τ, we reanalyzed the data from the MS study at
NINDS across a variety of values of τ. The results from this analysis are
shown in Fig. A.4, and show stability in the normalization for the T1-
based, T2-based, and hybrid white stripe normalizations for τ ranging
from 1% to 10%. For τ = 20%, the T1-based normalization technique
showed less comparable intensities across all tissue classes.
Appendix C. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2014.08.008.
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Fig. A.4. Bar plots showing the Hellinger distance-based variances before and after normalization in the NINDS study for various values of τ.
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